Received Feb 26, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPAB | HEP A + HEP B (TWINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
received twinrix 6 months ago and skipped the 2nd dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a female patient who received HAB (Twinrix adult) for prophylaxis. Previously administered products included twinrix adult (patient receive 1st dose on 5th September 2024, with batch number 4DS4N and expiry 25th September, 2026). On an unknown date, the patient did not receive the 2nd dose of Twinrix adult. On an unknown date, an unknown time after receiving Twinrix adult, the patient experienced incomplete course of vaccination (Verbatim: received twinrix 6 months ago and skipped the 2nd dose). The outcome of the incomplete course of vaccination was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 24-FEB-2025 Other HCP had a question regarding the Twinrix vaccine. Reported had a patient who got his First dose in September and reporter knew that Twinrix was given 0,1 and 6 months. However he was after 6 months, wanted to have the Second dose and in this case, reporter asked do they give him 2 more doses or just give 1 dose? Till the time of reporting patient did not receive 2nd dose of Twinrix which led to incomplete course of vaccination. This case is 1 of 2 cases reported by same reporter.; Sender's Comments: US-GSK-US2025023096:Same reporter different patient